Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20126557 | 0.85 | CYP1A2 (0.38) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL17640842 | 0.82 | CYP1A2 (0.33) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL20126560 | 0.80 | CYP1A2 (0.35) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL17640843 | 0.71 | CYP1A2 (0.42) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL15681464 | 0.70 | NOS1 (0.41) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL14183934 | 0.70 | NOS1 (0.41) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL4899817 | 0.70 | NOS1 (0.41) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL15490645 | 0.70 | CYP1A2 (0.42) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 | |
| SCHEMBL13911571 | 0.70 | NOS1 (0.33) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL7025313 | 0.70 | CYP2C19 (0.51) | CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10287245-B2 | Liquid thioether carboxylic acid esters | BASF SE (DE) | 2019-05-14 | — | — | US | disclosed |
| US-20180127363-A1 | LIQUID THIOETHER CARBOXYLIC ACID ESTERS | BASF SE (DE) | 2018-05-10 | — | — | US | disclosed |
| US-20180127363-A1 | LIQUID THIOETHER CARBOXYLIC ACID ESTERS | BASF SE (DE) | 2018-05-10 | — | — | US | disclosed |
| WO-2016046292-A1 | LIQUID THIOETHER CARBOXYLIC ACID ESTERS | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127363-A1 | LIQUID THIOETHER CARBOXYLIC ACID ESTERS | ALAD, TIPRL, CA7 | CYP1A2 4002/4885CYP2C9 1378/4885CYP2C19 1816/4885 |
| US-10287245-B2 | Liquid thioether carboxylic acid esters | ALAD, TIPRL, CA7 | CYP1A2 4002/4885CYP2C9 1378/4885CYP2C19 1816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.